Vision Marine Technologies, Inc. engages in the design, development, and manufacturing of electric outboard powertrain systems and electric boats. It operates through the Sale of Electric Boats and Rental of Electric Boats segments. The Sale of Electric Boats segment involves the manufacture of customized boats for the consumer market, sale of parts, and maintenance. The Rental of electric boats segment includes short-term rental operations and boat club membership. The company was founded by Patrick Bobby and Alexander Mongeon in 1995 and is headquartered in Boisbriand, Canada.

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.

authID, Inc. engages in the delivery of secure, mobile, and biometric identity solutions. It operates through the Verified Authentication Business segment. The company was founded by Thomas R Snoke on September 21, 2011 and is headquartered in Denver, CO.

Haoxi Health Technology Ltd. is a holding company, which engages in the provision of internet marketing solutions. It offers services for various industries to reduce risks, reduce operating costs, and ensure greater profits through in-depth insights into strategy, creativity, media integration, and industry development. The company was founded on August 5, 2022 and is headquartered in Beijing, China.

Damon, Inc. operates as a holding company that provides data analytics and statistical visualization solutions. The company was founded on October 17, 2023 and is headquartered in Vancouver, Canada.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jorgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgard Schambye in 2011 and is headquartered in Boston, MA.

Junee Ltd. operates as a holding company which provides interior design and fit-out services. It offers design, fit out and repair and maintenance services for commercial and residential buildings. The firm's interior design services include preliminary consulting services, conceptualizing clients design ideas with layout plans, and producing detailed design drawings. Its Fit-out services include activities making an interior space suitable for residential or commercial purposes. The company was founded on August 25, 2021, and is headquartered in Hong Kong.

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.